MicroRNA and genomic instability (Prof. Clark C. Chen)
Date: 30 November
Venue: SciLifeLab (Tomtebodavägen 23A, Solna), Gamma 2 Pantry
Clark C. Chen is a nationally recognized neurosurgeon, radiosurgery expert, and a renowned brain tumor researcher. His research interest is focused on understanding the neuroscience how normal brain interface with brain tumor cell and on developing new treatments for brain cancer patients. He received his B.S. in biology from Stanford University, M.S. in epidemiology from Columbia University, and M.D., Ph.D. from Harvard Medical School. As a Ph.D. candidate, Dr. Chen studied under Dr. Richard Kolodner, a Nominee for the 2015 Nobel Prize in Chemistry, and discovered the genetic basis of familial cancer predisposition syndromes. He subsequently completed his neurosurgery training at the Massachusetts General Hospital, Harvard Medical School. His clinical neurosurgical training included dedicated fellowships in radiosurgery and stereotactic neurosurgery. He currently serves as the Lyle French Chair in Neurosurgery and the Head of the University of Minnesota Medical School Department of Neurosurgery. Prior to this role, Dr. Chen served as the Vice-Chairman of Neurosurgery at the University of California San Diego and the Director of Surgical Neuro-oncology at the Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Chen is an NIH funded investigator and the recipient of highly regarded awards including: the Damon Runyon Fellowship Award, the Burroughs Wellcome Foundation Career Award in Medical Sciences, the Sontag Foundation Distinguished Scientist Award, the Doris Duke Foundation Clinical Scientist Award, and the Forbeck Scholar award. In 2015, Dr. Chen received the Presidential Award of Achievement from the President of Taiwan, Ma Ying-jeou. The award is conferred by the Taiwanese government to individuals of Taiwanese heritage who have made exceptional contributions to their profession.
Host: Jiri Bartek (Karolinska Institutet/SciLifeLab)